Immunochemical detection of acetaminophen-bound liver proteins.

[1]  J. D. Sun,et al.  Macromolecular weight specificity in covalent binding of bromobenzene. , 1984, Toxicology and applied pharmacology.

[2]  G. Ginsberg,et al.  Protection against acetaminophen-induced hepatotoxicity by prior treatment with fenitrothion. , 1982, Toxicology and Applied Pharmacology.

[3]  J R Gillette,et al.  Commentary. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity. , 1974, Biochemical pharmacology.

[4]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[5]  T. Baillie,et al.  The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. , 1984, Chemico-biological interactions.

[6]  J. Gillette.  A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding. , 1974, Biochemical pharmacology.

[7]  C. Heidelberger,et al.  Separate identities of ligandin and the h-protein, a major protein to which carcinogenic hydrocarbons are covalently bound. , 1976, Biochemical and biophysical research communications.

[8]  B. K. Park,et al.  Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to protein-reactive drugs and metabolites: criteria for identification of antibody activity. Detection and hapten specificity of anti-DNP, anti-captopril and anti-sulphanilamidobenzoic acid. , 1986, Journal of immunological methods.

[9]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.